Recent Updates
Recently added Catalysts
MDAI Positive Sentiment

Spectral AI Announces 2026 Second Quarter Financial Results

Tuesday, August 11, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Spectral AI, Inc. has reported its financial results for the second quarter of 2026, highlighting progress towards its first commercial sales of the DeepView® System aimed at treating burn indications. The company maintains a robust cash position of $14.0 million as of June 30, 2026, indicating financial stability as it moves forward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Company is advancing towards first commercial sales.
  • Strong cash position of $14.0 million.
  • Focus on the DeepView® System for burn indication.

Full Press Release Details

Company Continues to Advance Towards First Commercial Sales of the DeepView ® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence

Frequently Asked Questions

What were Spectral AI's financial results for Q2 2026?

Spectral AI reported a strong cash position of $14.0 million as of June 30, 2026.

What is the DeepView® System used for?

The DeepView® System is aimed at treating burn indications.

When does Spectral AI expect to make its first commercial sales?

The company is advancing towards its first commercial sales but did not specify a date.

ShareAdd on Google
Tags: MDAI Viatris Investor Conferences Healthcare Spectral AI DeepView System burn indication Q2 2026
Last updated: Aug 11, 2026

Biotech snapshot

Cash runway
$14M liquidity · $1M/mo burn
~10 mo
Medium dilution risk